INTRODUCTION
Age-related physiological and pathological changes contribute to the pharmacokinetic and pharmacodynamic alterations of drug metabolism in the elderly. Furthermore, many elderly individuals have several chronic illnesses that require multiple medications, which makes them more easily exposed to drug adverse events, as well as, drug interactions. Therefore, greater attention is needed in the medical management of elderly . In attempts to reduce the risk of medication-related problems in elderly patients, which usually accompany increase in health-care cost and poor outcomes, monitoring and analysis of prescriptions for the elderly have been conducted in many developed countries [1] [2] [3] [4] . As a result of these efforts, various criteria have been developed worldwide for identifying potentially inappropriate medication (PIM) use and to evaluate their effects on elderly patients. Among these, the Beers criteria put together by the American Geriatric Society has been most widely used, which contains the list of medications considered potentially inappropriate for older patients. Since 1997, the Beers criteria had been updated several times; and finally, the updated 2012 Beers criteria was introduced 5) . By incorporating the latest and newest evidences of medications and specific conditions, 53 or medication classes are listed in the final updated version, which are divided into three categories: PIMs and classes to avoid in older adults, PIMs and classes to avoid in older adults with certain diseases and syndromes that the drugs listed can exacerbate, and medications to be used with caution in older adults. Further, this version presents the quality of evidence and strength of recommendation for each PIM to support the evidence-based approach and adequate application in the clinic.
There have been few reports dealing with the prevalence of PIMs prescriptions or their adverse effects on elderly patients in South Korea. To our knowledge, there have been no reports on the prevalence of PIMs prescriptions in South Korea using the 2012 version of the Beers criteria. Hence, focusing on physician's decisions, we aimed to summarize the prevalence of PIMs prescriptions and common PIMs used for elderly patients based on the 2012 updated version of the Beers criteria. We hope our findings will be shared not only to increase awareness, but also to improve the care of the elderly in South Korea.
MATERIALS AND METHODS

Study subjects
This is a retrospective study using medical records and code analysis of each medication. The survey was confined to outpatients seen between May 2012 and April 2013 at the Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, which is a 2,700-bed tertiary care teaching hospital. Subjects were restricted to those older than 65 years who received at least one medication under ambulatory care. Visits without intention for medical treatment but for issuance of documents or simple checkups without prescription were excluded.
PIMs were defined as all 53 medications or medication classes listed in the 2012 Beers criteria. Locating the possible PIMs was carried out by code analysis. The PIMs that cannot be prescribed at our center were excluded.
All data were analyzed regardless of the department that provided the care. Being a retrospective surveillance study using code analysis, there are limitations to classifying patient's characteristics.
Methods
The main outcomes were to identify the rate of PIM prescriptions in elderly outpatients, as well as, to identify common PIMs. Each ingredient of PIM was investigated in all patients included. The total number of patients who received at least one PIM was investigated. And the number of patients who received PIMs and the number of PIM prescriptions were abstracted. The 1-year incidence rate of patients prescribed PIMs and incidence rate of PIM prescriptions were calculated. The PIMs identified in this study were listed by frequency and validated on their level of evidence and recommendation proposed by the 2012 Beers criteria.
The Asan Medical Center has one of the largest cancer centers in South Korea. The large number of cancer patients could potentially disturb the PIM incidence or ranking. Thus, cancer patients were separated from noncancer patients who received PIMs, and then the proportion of cancer patients was calculated.
Statistical analysis
Statistical analyses were performed on the IBM SPSS ver. 18.0 (IBM Co., Armonk, NY, USA).
RESULTS
From May 2012 to April 2013, a total of 652,192 outpatients older than 65 years visited our medical center. The median age was 84.5 years (range, 65 to 104 years) and 47.79% were female. Of all elderly outpatients, 33,810 (5.19%) were prescribed at least one PIM listed in the 2012 Beers criteria. A total of 125,498 events of PIM prescriptions occurred during the study period.
The number of elderly patients prescribed at least one PIM concurrently was 22,607 (66.86%), of which the average num- ber of PIM ingredient was 1.56. Patients prescribed at least two potentially inappropriate ingredients at the same time were 11,203 (33.14%). Additionally, 4,383 patients (12.38%) received over three concurrent PIMs, and 1,526 (4.51%) patients were prescribed more than four PIMs. Table 1 lists the fifteen common PIMs prescribed at the Asan Medical Center according to the 2012 Beers criteria. The most frequent PIM was tramadol at 24.15% (8,166/ 33,810) . A total of 17,449 cases were prescribed tramadol during the study period. The second common PIM was clonazepam (11.51% of elderly patients; 11,378 prescription cases), followed by ibuprofen (10.02% of patients; 5,518 prescription cases), megesterol (9.80% of patients; 3,315 prescription cases), and amitriptyline (9.51% of patients; 3,215 prescription cases). The top fifteen common PIMs were medications that have a "strong" level of recommendation by the 2012 Beers criteria. Table 2 shows the prevalence of antipsychotic prescriptions listed in the 2012 Beers criteria. Antipsychotics were prescribed to 2,474 patients and 8,376 cases of antipsychotics prescription were identified. Quetiapine was the most common PIM among the antipsychotics with 79.35% of the elderly patients using it and 1,963 cases of quetiapine prescriptions. Olanzapine was ranked second at 9.01% and 749 prescription cases. The top five most common antipsychotics were those classified as second-generation antipsychotics.
The common antidepressants PIMs having strong anticholinergic properties are listed in Table 3 . A total of 4,376 patients received at least one antidepressant with 11,385 prescriptions written. Amitriptyline was the most common antidepressant with 73.47% of the elderly patients on it. The number of prescriptions of amitriptyline written (8, 395 ) far exceeded the amounts of the other antidepressants. Table 4 shows the commonly prescribed benzodiazepines with strong anticholinergic properties. A total of 9,687 patients were exposed to the benzodiazepines classified as PIM. The number of benzodiazepine prescriptions written was 27,649. Among these, 3,892 patients (40.18%) were prescribed clonazepam, followed by alprazolam (30.49%), lorazepam (13.44%), diazepam (9.23%), and triazolam (6.10%).
DISCUSSION
The efforts to define inappropriate medications for the Calculated by (the number of cases of each PIM prescription) per (total number of antidepressants prescriptions). elderly have been ongoing for several decades in foreign countries. Many screening tools for elderly medications, the Beers criteria, and the screening tool of older person's prescriptions (STOPP) are widely accepted by physicians 6, 7) . Before the updated 2012 Beers criteria, the 2002 version was used. However, there were several weaknesses -it had only a simple list of inappropriate medications without classifications and several older medications no longer available were included. Thus, it was not only outdated but also inconvenient to use. Owing to its limitations, the STOPP criteria was introduced in 2008 7) . Another screening tool, the STOPP criteria was developed for the general elderly population. Sixty-five medications commonly used in the elderly are categorized by physiologic system. It also contains the adequacy of prescriptions, which includes the appropriate selection of drugs, proper duration, and their interactions considering underlying diseases or other drugs. There are several studies that compared the Beers criteria with STOPP to evaluate their efficacy [8] [9] [10] . However, previous analyses compared the 2002 version of the Beers criteria and the STOPP criteria. In an attempt to overcome its shortcomings, the new version of the Beers criteria was published in 2012, which includes well-organized lists of PIMs for elderly, as well as, their level of evidence with recommendations reflecting the latest knowledge.
In spite of global efforts, there are only a few reports in South Korea focusing on inappropriate medications in elderly patients or their adverse drug events. There was a single center investigation that evaluated the PIM prescription in elderly patients using the 2002 Beers criteria. Medical records from 4,519 in-patients and 20,575 outpatients were reviewed. The reports showed that 57% of in-patients and 27.8% of outpatients received at least one PIM. Ketorolac (17%), short-acting nifedipine (9.7%), triazolam (8.9%), diazepam (8.8%), and lorazepam (8.5%) were common PIMs in in-patients. Amitriptyline, flurazepam, short-acting benzodiazepine use longer than one week, and naproxen were frequent PIMs for out-patients. There are several reports using data from the National Health Insurance claim to evaluate the prevalence of PIM prescription [11] [12] [13] . These reports include elderly patients across the nation who visited any medical center or clinic in South Korea between January 2005 and June 2006. PIMs were also defined by the 2002 Beers criteria. According to these reports, common PIMs were diazepam (40.62%), amitriptyline (9.64%), ketorolac (2.55%), alprazolam (over 30 days, 1.73%), and lorazepam (over 30 days, 0.52%). Another report from Chung et al 14) retrospectively analyzed the prescription pattern from elderly patients admitted to a single center for six months. They referred to the list of PIMs from Zhan's classification and the 2002 Beers criteria. According to these reports, 42.7% of the total 5,498 elderly patients received at least one PIM during admission. Frequent medications were ketorolac (30%), pethidine (27.8 %), and diazepam (16.0%). In the community-dwelling elderly populations, prescribing patterns were assessed from 80 individuals. The median number of pills was 7.23, and the common PIMs according to the 2002 Beers criteria were aspirin (21%), amitriptyline (4%), and short-acting benzodiazepines (4%) 15) . Other studies were limited to several medications or specific medical conditions occurring in elderly patients. There was an attempt to develop a list of PIMs for the Korean elderly population 16) . By the Delphi technique, they created a list of 57 PIMs by each diagnosis. These PIMs were classified into 3 groups. Considering 29 specific conditions, a list of 93 PIMs were also suggested. However, this suggested list of PIMs for the Korean elderly population was neither verified nor widely accepted.
On summarizing previous Korean reports, amitriptyline, ketorolac, and long-acting benzodiazepines, especially diazepam seemed to be the most common PIMs in South Korea. However, these medications concord with the ones emphasized by the Beers criteria. That is why we should study the current Korean status of PIM prescription as soon as possible. On the other hand, there were few systematic studies with a large number of elderly patients. Furthermore, to our knowledge, there has been no Korean report using the updated 2012 Beers criteria.
We surveyed the prevalence of PIM prescriptions for outpatients at a single tertiary medical center. 33,810 elderly patients received at least one PIM at a percentage of 5.19% of elderly patients. 125,498 cases of PIMs were prescribed during the study period. During one year, over half of the elderly patients (66.86%) received one PIM from physicians. 33.14% of the patients received more than two PIMs concurrently. Although exact comparison is difficult due to the scarcity of previous results, still a considerable number of Korean elderly patients are exposed to PIMs. Regardless of the percentage of patients with PIMs, for whatever reasons that PIMs are prescribed, it is remarkable that tens of thousands of patients have received the PIMs, even at a tertiary medical center.
Important to note here is that the pattern of common PIMs at our center is different from other reports. The common PIMs were tramadol (24.15%), clonazepam (11.51%), ibuprofen (10.02%), megesterol (9.80%), and zolpidem (9.60%), which is a unique ranking compared to other reports.
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The updated 2012 Beers criteria recommends tramadol be avoided in the case of chronic seizures or epilepsy due to the possibility of disease exacerbation 5) . And some other common PIMs listed in Table 1 , such as pseudoephedrine, cilostazol, and quetiapine, are included in the same group of PIMs that should be avoided in older adults with certain diseases or syndromes, which could be exacerbated (Table 1) . We did not investigate the purpose, dosage, and duration of each PIM. Considering this, the number of PIM prescriptions in not recommended situations might be reduced.
The use of tramadol, megesterol, amitriptyline, metoclopramide, and lorazepam are relatively more frequent than seen in other results. Because this survey was performed at a tertiary hospital with one of the largest cancer centers in South Korea, we carried out further analysis to find out the proportion of cancer patients from each PIM group. We revealed that 38.80% of cancer patients were included in the total 33,810 patients who received at least one PIM (Table 1 ). More specifically, medications frequently used with chemotherapy include tramadol (26.67%), megesterol (64.10%), metoclopramide (59.43%), and lorazepam (35.18%). Megesterol is a new drug added to the 2012 Beers criteria. These PIMs are widely used for relieving side effects of chemotherapy in cancer patients and supported by the national insurance guideline. It appears that the large proportion of cancer patients and the insurance guideline contributed to the prevalence and rank of common PIMs in our report.
The most common PIM in our report, tramadol, is remarkable. Except for relief of cancer pain or epilepsy, the absolute number of tramadol prescription is still seemingly high leading to the assumption that considerable cases of tramadol prescription are likely for pain relief. According to a report from the Centers for Disease Control and Prevention in the USA, with the rise in the use of analgesics, deaths from overdose of pain killers have been gradually increasing 17) . There needs to be a greater concern about the use of tramadol in elderly patients.
In the case of benzodiazepines having strong anticholinergic properties, this study shows the overwhelming use of quetiapine as an antipsychotic drug (Table 2 ). There was a relatively less frequent use of diazepam but more frequent use of clonazepam and alprazolam. Considering that tertiary medical centers see high numbers of patients with comorbidities, the frequent use of benzodiazepines might be associated with the severity of the patients' condition. In the 2012 Beers criteria, quetiapine belongs to two categories-PIMs and classes to avoid in older adults and PIMs and classes to avoid in older adults with certain diseases and syndromes that the drugs listed can exacerbate. The 2012 Beers criteria insists that antipsychotics be avoided in managing dementia as these medications can increase risk of cerebrovascular accident and mortality. In addition, quetiapine is not recommended in use for Parkinson disease. More careful use of antipsychotics, especially quetipine, is needed.
This study has several weaknesses. Since this study was originally designed as a prevalence survey based on the retrospective code analysis, information about doses or duration of PIMs, patient compliance, comorbidity, and diagnosis are not reflected fully. The number of prescriptions may not coincide with actual administration. However, our study focused mainly on physician's practice rather than the characteristics of patients focused on by other studies. And also, the Beers criteria were created to measure the pharmacological appropriateness of prescriptions and not to replace careful clinical decision-making 18) . It allows for a relative assessment of drug use risk in the elderly and might also be used as a screening and educational tool to identify potential drug-related problems when other information sources are lacking 19) . That is, there would be certain inevitable limitations to evaluate PIMs use accurately.
Despite these limitations, this study has several advantages. Even though this is a single center study, a large number of patients were enrolled. Entire outpatients who visited our center for one-year were enrolled. Worthy to note is that it is the first observational study conducted using the 2012 Beers criteria in South Korea. Every PIM in the 2012 Beers criteria was reviewed for each subject. We compared not only the incidence of patients with PIMs but also that of each PIM. By presenting the absolute number of PIM prescription with current frequency of common PIMs in a tertiary medical center, our results could lead physicians to be more careful when prescribing to elderly patients, particularly high incidence of PIMs.
Although the Beers criteria is the gold standard for assessing PIMs in the elderly, several authors have formulated new explicit and implicit criteria that have been adapted for a specific country 18) . We suggest that the study into the Korean elderly population and adverse drug events in this population continue. We hope this study motivates physicians to have a greater interest in the use of medications in the elderly.
This study shows the prevalence of PIMs prescription in Korean elderly outpatients at a single tertiary medical center. It is important that physicians be better educated about and more attentive to medication use in the elderly patients. 
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